Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-26

Clinical Trial Update: A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating duloxetine for migraine prevention. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Migraine | Phase 4 | Status: COMPLETED | Results posted: 2014-05-26